Araştırma Çıktıları

Permanent URI for this communityhttps://hdl.handle.net/11443/931

Browse

Search Results

Now showing 1 - 2 of 2
  • Item
    Botulinum Toxin in Migraine Treatment
    (TURKISH NEUROPSYCHIATRY ASSOC-TURK NOROPSIKIYATRI DERNEGI, 2013-01-01) Aydinlar, Elif Ilgaz; Dikmen, Pinar Yalinay; Kocaman, Ayse Sagduyu
    Since botulinum toxin might have a therapeutic effect on pain, many studies investigating the efficiency of botulinum toxin in headache treatment have been done. The most satisfying results were achieved by botulinum toxin type A (BoNT/A) in the treatment of chronic migraine. In this paper, we reviewed the clinical effectiveness of BoNT/A in migraine and included our clinical experience. In our ongoing pilot study, where we have repeated BoNT/A injections every 12 weeks, The difference in the Migraine Disability Assessment (MIDAS) scores between the first and the second injections was 61.1\%
  • Thumbnail Image
    Item
    Diagnosis and Treatment in Vestibular Migraine
    (TURKISH NEUROLOGICAL SOC, 2020-01-01) Dikmen, Pinar Yalinay
    Vestibular migraine (VM) is the most common cause of recurrent spontaneous vertigo. Inclusion of the diagnostic criteria for VM in the last edition of the International Classification of Headache Disorders published in 2013 promoted the establishment of unity in terminology as well as increasing awareness about VM. The diagnosis of VM is based on clinical history. In studies related to VM, it has been shown that headache and vertigo may not always occur simultaneously, and vertigo may present in different patterns in individual attacks of patients. This variation creates difficulty in the diagnosis of VM. Therefore, the presence of headache should always be questioned in young and middle-aged patients who present with vertigo. Headache that was present previously may have disappeared years ago, hence a detailed patient history is the most essential tool in the diagnosis of VM. There may be some findings showing central and peripheral vestibular involvement in the neurotologic examination during ictal and interictal periods. However, there is no pathognomonic laboratory test